Evaluating non-invasive neurostimulation for frozen shoulder treatment
Prise En Charge Des Atteintes Proprioceptives Chez Une Population Avec Capsulite Rétractile
This study is testing if a new non-invasive treatment using brain stimulation and tendon vibration can help people with frozen shoulder feel better compared to a placebo.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Université du Québec à Chicoutimi Academic / other |
| Locations | 1 site (Saguenay, Quebec) |
| Trial ID | NCT06795932 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to assess the effectiveness of non-invasive neurostimulation devices, specifically transcranial magnetic stimulation (TMS) and tendon vibration, in treating adhesive capsulitis, commonly known as frozen shoulder. Participants will be divided into two groups: one receiving the actual intervention combined with standardized exercises, and the other receiving a placebo intervention. The study will compare the somatosensory processing and corticospinal excitability between individuals with adhesive capsulitis and healthy controls, with the goal of establishing a better understanding of the condition and its treatment. The trial seeks to provide empirical evidence on the neurophysiological effects of these interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and over who have been diagnosed with adhesive capsulitis.
Not a fit: Patients with cognitive disorders, neurological diseases affecting the upper limbs, or a history of shoulder surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients suffering from adhesive capsulitis, enhancing their recovery and quality of life.
How similar studies have performed: While the use of neurostimulation in treating adhesive capsulitis is relatively novel, similar approaches in other conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old and over * Good general health * Adhesive capsulitis (experimental group) or * No shoulder pain (placebo group) Exclusion Criteria: * Cognitive disorders; * Any neurological disease/injury affecting the upper limbs; * History or diagnosis of muscle, tendon, or capsular tear; * Shoulder surgery/prosthesis; * Pregnant woman; * Presence of metal in the skull or jaw; * History of epilepsy.
Where this trial is running
Saguenay, Quebec
- Lab BioNR - UQAC — Saguenay, Quebec, Canada (Recruiting)
Study contacts
- Study coordinator: Émilie Bouchard, M.Sc. PhD candidate
- Email: e4bouch@uqac.ca
- Phone: 581-882-0300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.